Skip to content

Clinical trials

Recruiting Carcinoma, Hepatocellular trials in Taiwan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Hepatocellular Status: Recruiting Country / region: Taiwan Clear all

32 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20201
20211
20226
20232
20249
202510
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting32

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Chang Gung Memorial Hospital7
AstraZeneca3
DualityBio Inc.2
Kaohsiung Medical University Chung-Ho Memorial Hospital2
National Taiwan University Hospital2
AbbVie1
Bristol-Myers Squibb1
Daiichi Sankyo1
Eureka Therapeutics Inc.1
Febico Biomedical Corp.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Hepatocellular32
Carcinoma, Non-Small-Cell Lung5
Neoplasms4
Squamous Cell Carcinoma of Head and Neck4
Liver Neoplasms3
Melanoma3
Biliary Tract Neoplasms2
Esophageal Squamous Cell Carcinoma2
Ovarian Neoplasms2
Small Cell Lung Carcinoma2

Trials

Showing 1 to 25 of 32. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.